| Nome |
# |
|
Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial, file e3ad8920-83ae-da0e-e053-3705fe0a2b96
|
4.825
|
|
Diet, Weight Loss, and Liver Health in NAFLD: Pathophysiology, Evidence and Practice, file e3ad8918-825a-da0e-e053-3705fe0a2b96
|
865
|
|
Transmembrane 6 Superfamily Member 2 Gene Variant Disentangles Nonalcoholic Steatohepatitis From Cardiovascular Disease, file e3ad8916-d379-da0e-e053-3705fe0a2b96
|
553
|
|
Lean NAFLD: A Distinct Entity Shaped by Differential Metabolic Adaptation, file e3ad8927-d81b-da0e-e053-3705fe0a2b96
|
542
|
|
Liver stiffness quantification in patients with non-alcoholic steatohepatitis: comparison of shear wave elastography and transient elastography with liver biopsy correlation, file 077f1828-dc7a-4ec0-a011-2c2489011b3b
|
508
|
|
Steatosis affects the performance of liver stiffness measurement for fibrosis assessment in patients with genotype 1 chronic hepatitis C, file e3ad8916-ddea-da0e-e053-3705fe0a2b96
|
416
|
|
The combination of liver stiffness measurement and NAFLD fibrosis score improves the noninvasive diagnostic accuracy for severe liver fibrosis in patients with nonalcoholic fatty liver disease., file e3ad8916-cfd9-da0e-e053-3705fe0a2b96
|
370
|
|
Hepatic steatosis and insulin resistance are associated with severe fibrosis in patients with chronic hepatitis caused by HBV or HCV infection., file e3ad8916-ddec-da0e-e053-3705fe0a2b96
|
351
|
|
Naïve hepatitis B e antigen-negative chronic hepatitis B patients are at risk of carotid atherosclerosis: A prospective study, file e3ad8927-a90e-da0e-e053-3705fe0a2b96
|
325
|
|
TM6SF2 rs58542926 is not associated with steatosis and fibrosis in largecohort of patients with genotype 1 chronic hepatitis C, file e3ad891b-033f-da0e-e053-3705fe0a2b96
|
292
|
|
Hepatitis C Virus Eradication by Direct Antiviral Agents Improves Carotid Atherosclerosis in patients with Severe Liver Fibrosis, file e3ad891c-add2-da0e-e053-3705fe0a2b96
|
286
|
|
Visceral adiposity index is associated with significant fibrosis in patients with non-alcoholic fatty liver disease, file e3ad8916-ed8e-da0e-e053-3705fe0a2b96
|
284
|
|
A "systems medicine" approach to the study of non-alcoholic fatty liver disease, file e3ad8918-7e55-da0e-e053-3705fe0a2b96
|
269
|
|
Liver eosinophilic infiltrate is a significant finding in patients with chronic hepatitis C., file e3ad8919-b138-da0e-e053-3705fe0a2b96
|
237
|
|
The presence of White Matter Lesions is not associated with Non-alcoholic Fatty Liver Disease but with its histological severity, file e3ad891c-f2e5-da0e-e053-3705fe0a2b96
|
203
|
|
Boceprevir is highly effective in treatment-experienced hepatitis C virus-positive genotype-1 menopausal women, file e3ad8918-8dba-da0e-e053-3705fe0a2b96
|
201
|
|
PNPLA3 GG Genotype and Carotid Atherosclerosis in Patients with Non-Alcoholic Fatty Liver Disease, file e3ad8916-a2c9-da0e-e053-3705fe0a2b96
|
194
|
|
Reactive hyperemia index (RHI) and cognitive performance indexes are associated with histologic markers of liver disease in subjects with non-alcoholic fatty liver disease (NAFLD): a case control study., file e3ad891c-d676-da0e-e053-3705fe0a2b96
|
194
|
|
Obstructive Sleep Apnea Is Associated with Liver Damage and Atherosclerosis in Patients with Non-Alcoholic Fatty Liver Disease, file e3ad8918-87d9-da0e-e053-3705fe0a2b96
|
178
|
|
Comparison of Histochemical Stainings in Evaluation of Liver Fibrosis and Correlation with Transient Elastography in Chronic Hepatitis, file e3ad8918-8032-da0e-e053-3705fe0a2b96
|
177
|
|
Genetic background in nonalcoholic fatty liver disease: A comprehensive review, file e3ad8918-7caa-da0e-e053-3705fe0a2b96
|
172
|
|
Insulin resistance and hyperandrogenism drive steatosis and fibrosis risk in young females with PCOS, file e3ad891b-9c02-da0e-e053-3705fe0a2b96
|
165
|
|
The Hepatic Expression of Vitamin D Receptor is Inversely Associated with the Severity of Liver Damage in Genotype 1 Chronic Hepatitis C Patients., file e3ad8916-ea69-da0e-e053-3705fe0a2b96
|
161
|
|
The presence of white matter lesions is associated with the fibrosis severity of nonalcoholic fatty liver disease, file e3ad8919-5179-da0e-e053-3705fe0a2b96
|
154
|
|
MAFLD: a multisystem disease, file 879e770d-592b-41b4-92e0-79bec59cbc9b
|
152
|
|
Antidiabetic drugs in NAFLD: The accomplishment of two goals at once?, file e3ad891e-ef11-da0e-e053-3705fe0a2b96
|
150
|
|
Ovarian senescence increases liver fibrosis in humans and zebrafish with steatosis, file e3ad8918-821d-da0e-e053-3705fe0a2b96
|
149
|
|
NT pro BNP plasma level and atrial volume are linked to the severity of liver cirrhosis., file e3ad8916-a282-da0e-e053-3705fe0a2b96
|
141
|
|
Protein phosphatase 1 regulatory subunit 3B gene variation protects against hepatic fat accumulation and fibrosis in individuals at high risk of nonalcoholic fatty liver disease, file e3ad891e-ef0c-da0e-e053-3705fe0a2b96
|
138
|
|
Increased serum miR-193a-5p during non-alcoholic fatty liver disease progression: Diagnostic and mechanistic relevance, file e3ad8927-e920-da0e-e053-3705fe0a2b96
|
138
|
|
Role of myeloid-epithelial-reproductive tyrosine kinase and macrophage polarization in the progression of atherosclerotic lesions associated with nonalcoholic fatty liver disease, file e3ad8920-83b2-da0e-e053-3705fe0a2b96
|
137
|
|
Rare Pathogenic Variants Predispose to Hepatocellular Carcinoma in Nonalcoholic Fatty Liver Disease, file e3ad891e-b832-da0e-e053-3705fe0a2b96
|
133
|
|
Premature ovarian senescence and a high miscarriage rate impair fertility in women with HCV, file e3ad891b-be40-da0e-e053-3705fe0a2b96
|
129
|
|
Fibrosis Evaluation by Transient Elastography in Patients With Long-Term Sustained HCV Clearance, file e3ad8916-5e58-da0e-e053-3705fe0a2b96
|
126
|
|
Development and Validation of Hepamet Fibrosis Scoring System A Simple, Noninvasive Test to Identify Patients With Nonalcoholic Fatty Liver Disease With Advanced Fibrosis, file e3ad8920-6e21-da0e-e053-3705fe0a2b96
|
125
|
|
Hepatitis C virus and cardiovascular: A review, file e3ad891b-db77-da0e-e053-3705fe0a2b96
|
124
|
|
The burden of hepatocellular carcinoma in non-alcoholic fatty liver disease: Screening issue and future perspectives, file e3ad8920-83a9-da0e-e053-3705fe0a2b96
|
123
|
|
Reply to: "IL28B rs12979860 is not associated with histologic features of NAFLD in a cohort of Caucasian North American patients"., file e3ad8916-58eb-da0e-e053-3705fe0a2b96
|
116
|
|
Pharmacological therapy of non-alcoholic fatty liver disease: What drugs are available now and future perspectives, file e3ad8920-85d4-da0e-e053-3705fe0a2b96
|
114
|
|
MBOAT7 rs641738 variant and hepatocellular carcinoma in non-cirrhotic individuals, file e3ad891b-c011-da0e-e053-3705fe0a2b96
|
109
|
|
Reply to: Is industrial fructose just a marker of an unhealthy dietary pattern?, file e3ad8916-a303-da0e-e053-3705fe0a2b96
|
108
|
|
Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016–2030, file e3ad891e-ef15-da0e-e053-3705fe0a2b96
|
93
|
|
Pathophysiology of non alcoholic fatty liver disease, file e3ad891b-a572-da0e-e053-3705fe0a2b96
|
92
|
|
PSD3 downregulation confers protection against fatty liver disease, file e3ad8927-e91d-da0e-e053-3705fe0a2b96
|
91
|
|
Serum coding and non-coding RNAs as biomarkers of NAFLD and fibrosis severity, file e3ad8920-83b0-da0e-e053-3705fe0a2b96
|
89
|
|
The severity of steatosis influences liver stiffness measurement in patients with nonalcoholic fatty liver disease, file e3ad8918-94a3-da0e-e053-3705fe0a2b96
|
88
|
|
Age as a Confounding Factor for the Accurate Non-Invasive Diagnosis of Advanced NAFLD Fibrosis, file e3ad891b-94d3-da0e-e053-3705fe0a2b96
|
87
|
|
Causal relationship of hepatic fat with liver damage and insulin resistance in nonalcoholic fatty liver, file e3ad8926-6752-da0e-e053-3705fe0a2b96
|
87
|
|
Telomerase reverse transcriptase germline mutations and hepatocellular carcinoma in patients with nonalcoholic fatty liver disease, file e3ad891b-a422-da0e-e053-3705fe0a2b96
|
76
|
|
Renin-angiotensin system inhibitors, type 2 diabetes and fibrosis progression: An observational study in patients with nonalcoholic fatty liver disease, file e3ad891b-b35d-da0e-e053-3705fe0a2b96
|
74
|
|
Macrophage MerTK promotes profibrogenic cross-talk with hepatic stellate cells via soluble mediators, file 6d08d5a6-6474-4f32-97a5-b3ae85ea84e5
|
67
|
|
Incidence of DAA failure and the clinical impact of retreatment in real-life patients treated in the advanced stage of liver disease: Interim evaluations from the PITER network, file e3ad891b-977a-da0e-e053-3705fe0a2b96
|
64
|
|
Association Between PNPLA3 rs738409 C>G Variant and Liver-Related Outcomes in Patients with Non-alcoholic Fatty Liver Disease, file e3ad8920-83a3-da0e-e053-3705fe0a2b96
|
62
|
|
Genetic variation in the TLL1 gene is not associated with fibrosis in patients with metabolic associated fatty liver disease, file e3ad8927-0068-da0e-e053-3705fe0a2b96
|
62
|
|
Iperuricemia: significato clinico e nuove prospettive di trattamento, file e3ad8917-01f9-da0e-e053-3705fe0a2b96
|
60
|
|
Exome-Wide Association Study on Alanine Aminotransferase Identifies Sequence Variants in the GPAM and APOE Associated With Fatty Liver Disease, file e3ad8927-bd8d-da0e-e053-3705fe0a2b96
|
53
|
|
Optimization of hepatitis C virus screening strategies by birth cohort in Italy, file e3ad8926-f4c1-da0e-e053-3705fe0a2b96
|
52
|
|
Position paper on liver and kidney diseases from the Italian Association for the Study of Liver (AISF), in collaboration with the Italian Society of Nephrology (SIN), file e3ad8927-ce83-da0e-e053-3705fe0a2b96
|
51
|
|
Diagnostic accuracy of elastography and magnetic resonance imaging in patients with NAFLD: A systematic review and meta-analysis, file e3ad8927-e22c-da0e-e053-3705fe0a2b96
|
51
|
|
L’insulino-resistenza è il principale fattore indipendente correlato con l’aumentato rischio metabolico nelle donne affette da PCOS, file e3ad891d-4c87-da0e-e053-3705fe0a2b96
|
49
|
|
Non-alcoholic fatty liver disease in adults 2021: A clinical practice guideline of the Italian Association for the Study of the Liver (AISF), the Italian Society of Diabetology (SID) and the Italian Society of Obesity (SIO), file e3ad8927-bbef-da0e-e053-3705fe0a2b96
|
48
|
|
Non-alcoholic fatty liver disease in adults 2021: A clinical practice guideline of the Italian Association for the Study of the Liver (AISF), the Italian Society of Diabetology (SID) and the Italian Society of Obesity (SIO), file e3ad8927-a7d1-da0e-e053-3705fe0a2b96
|
47
|
|
Dual proteotoxic stress accelerates liver injury via activation of p62-Nrf2, file e3ad8927-e3df-da0e-e053-3705fe0a2b96
|
47
|
|
qFIBS: A Novel Automated Technique for Quantitative Evaluation of Fibrosis, Inflammation, Ballooning, and Steatosis in Patients With Nonalcoholic Steatohepatitis, file 922b7fe6-e629-4205-8b09-90b95fcf3f38
|
46
|
|
Liver stiffness quantification in patients with non-alcoholic steatohepatitis: comparison of shear wave elastography and transient elastography with liver biopsy correlation, file e3ad891e-c6de-da0e-e053-3705fe0a2b96
|
46
|
|
Diagnostic accuracy of non-invasive tests for advanced fibrosis in patients with NAFLD: An individual patient data meta-analysis, file e3ad8927-bfad-da0e-e053-3705fe0a2b96
|
43
|
|
Liver stiffness quantification in biopsy-proven nonalcoholic fatty liver disease patients using shear wave elastography in comparison with transient elastography, file e3ad8927-286e-da0e-e053-3705fe0a2b96
|
41
|
|
Mistranslation Drives Alterations in Protein Levels and the Effects of a Synonymous Variant at the Fibroblast Growth Factor 21 Locus, file e3ad8927-bfab-da0e-e053-3705fe0a2b96
|
41
|
|
Non-alcoholic fatty liver disease in adults 2021: A clinical practice guideline of the Italian Association for the Study of the Liver (AISF), the Italian Society of Diabetology (SID) and the Italian Society of Obesity (SIO), file e3ad8927-e225-da0e-e053-3705fe0a2b96
|
41
|
|
First-Line Immune Checkpoint Inhibitor-Based Sequential Therapies for Advanced Hepatocellular Carcinoma: Rationale for Future Trials, file e3ad8927-f1d5-da0e-e053-3705fe0a2b96
|
38
|
|
FibroScan Identifies Patients With Nonalcoholic Fatty Liver Disease and Cardiovascular Damage, file e3ad891e-e174-da0e-e053-3705fe0a2b96
|
36
|
|
Metabolic signatures across the full spectrum of non-alcoholic fatty liver disease, file 0e0a06c9-56e3-44cc-86f7-403fd503daba
|
35
|
|
Heart rate variability is associated with disease severity and portal hypertension in cirrhosis, file dfacd35c-0c9d-4cd9-b9ae-9fc78730648f
|
35
|
|
Diet, Weight Loss, and Liver Health in NAFLD: Pathophysiology, Evidence and Practice, file e3ad8925-af15-da0e-e053-3705fe0a2b96
|
27
|
|
A Genetic and Metabolic Staging System for Predicting the Outcome of Nonalcoholic Fatty Liver Disease, file e3ad8928-65b7-da0e-e053-3705fe0a2b96
|
27
|
|
The MBOAT7-TMC4 Variant rs641738 Increases Risk of Nonalcoholic Fatty Liver Disease in Individuals of European Descent, file e3ad891b-db13-da0e-e053-3705fe0a2b96
|
22
|
|
LIPIDOMICS OF FATTY LIVER IN NAFLD AND HCV INFECTION: LIVER SPHYNGOLIPIDS AND FATTY
ACIDS, file e3ad8917-0e6a-da0e-e053-3705fe0a2b96
|
21
|
|
Clinical features and comorbidity pattern of HCV infected migrants compared to native patients in care in Italy: A real-life evaluation of the PITER cohort, file e3ad8927-c830-da0e-e053-3705fe0a2b96
|
21
|
|
Interplay between non-alcoholic fatty liver disease and cardiovascular risk in an asymptomatic general population, file e3ad8926-ebce-da0e-e053-3705fe0a2b96
|
19
|
|
Machine learning algorithm improves the detection of NASH (NAS-based) and at-risk NASH: A development and validation study, file f2ad9471-a00d-4f07-84e9-e8de2bb7c98c
|
18
|
|
Liver and cardiovascular mortality after hepatitis C virus eradication by DAA: Data from RESIST-HCV cohort, file e3ad8926-b3ad-da0e-e053-3705fe0a2b96
|
17
|
|
Healthcare resource utilization and costs of nonalcoholic steatohepatitis patients with advanced liver disease in Italy, file e3ad8926-ff80-da0e-e053-3705fe0a2b96
|
11
|
|
Lean NAFLD: A Distinct Entity Shaped by Differential Metabolic Adaptation, file e3ad8920-8202-da0e-e053-3705fe0a2b96
|
10
|
|
Association Between PNPLA3 rs738409 C>G Variant and Liver-Related Outcomes in Patients with Non-alcoholic Fatty Liver Disease, file e3ad8926-7f4c-da0e-e053-3705fe0a2b96
|
10
|
|
PNPLA3 rs738409 C>G Variant Predicts Fibrosis Progression by Noninvasive Tools in Nonalcoholic Fatty Liver Disease, file e3ad8926-ff7e-da0e-e053-3705fe0a2b96
|
10
|
|
Macrophage Scavenger Receptor 1 mediates lipid-induced inflammation in non-alcoholic fatty liver disease, file f902f349-119f-443c-a385-02cd416e07a3
|
10
|
|
Interaction between estrogen receptor-α and PNPLA3 p.I148M variant drives fatty liver disease susceptibility in women, file 14b50ba9-bc4c-459a-b862-527dee2ab56f
|
9
|
|
A prospective study on the prevalence of MASLD in people with type-2 diabetes in the community. Cost effectiveness of screening strategies, file 9de82b5b-519b-4252-9fe3-1b8778f1a2b9
|
9
|
|
Prevalence and Risk Factors of Significant Fibrosis in Patients With Nonalcoholic Fatty Liver Without Steatohepatitis, file e3ad8921-20f5-da0e-e053-3705fe0a2b96
|
9
|
|
Lean NAFLD: A Distinct Entity Shaped by Differential Metabolic Adaptation, file e3ad8925-99f8-da0e-e053-3705fe0a2b96
|
9
|
|
The European NAFLD Registry: A real-world longitudinal cohort study of nonalcoholic fatty liver disease, file e3ad8927-057a-da0e-e053-3705fe0a2b96
|
9
|
|
Non-invasive stratification of hepatocellular carcinoma risk in non-alcoholic fatty liver using polygenic risk scores, file e3ad8927-d965-da0e-e053-3705fe0a2b96
|
9
|
|
Noninvasive assessment of liver disease severity in patients with nonalcoholic fatty liver disease (NAFLD) and type 2 diabetes, file 521d4888-91f3-454e-b8b6-a560fd65ba4c
|
8
|
|
RESIST-HCV Criteria to Monitor Progression of Low-Risk Esophageal Varices in Patients With Compensated Cirrhosis After HCV Eradication: The SIMPLE Study: SIMPLE: Scoring Index to Monitor Progression of Low-risk Esophageal varices, file 86d1e742-6aec-43f8-b349-32d4e87bfae6
|
8
|
|
Reply, file e3ad8916-1579-da0e-e053-3705fe0a2b96
|
8
|
|
Transmembrane 6 Superfamily Member 2 Gene Variant Disentangles Nonalcoholic Steatohepatitis From Cardiovascular Disease, file e3ad891c-70e1-da0e-e053-3705fe0a2b96
|
8
|
|
Prevalence and Risk Factors of Significant Fibrosis in Patients With Nonalcoholic Fatty Liver Without Steatohepatitis, file e3ad891e-df43-da0e-e053-3705fe0a2b96
|
8
|
|
Disease outcomes after DAA-induced SVR: Data from the resist-HCV cohort, file e3ad891e-faad-da0e-e053-3705fe0a2b96
|
8
|
|
Prediction of Esophageal Varices by Liver Stiffness and Platelets in Persons with HIV infection and Compensated Advanced Chronic Liver Disease, file e3ad8920-6e24-da0e-e053-3705fe0a2b96
|
8
|
|
HBV reactivation in patients with HCV/HBV cirrhosis on treatment with direct-acting antivirals, file e3ad8923-d6a4-da0e-e053-3705fe0a2b96
|
8
|
| Totale |
16.367 |